Ticagrelor blocks the P2Y12 receptor on platelets, preventing them clumping together. Unlike clopidogrel it binds reversibly and does not need converting by a liver enzyme, so it works faster, more consistently, and in people whose genetics make clopidogrel unreliable. It is used after a heart attack and after stenting, alongside aspirin. It also causes breathlessness in a substantial minority - a side effect that feels cardiac, usually is not, and leads to a great deal of unnecessary stopping.
Follow the instructions on your label. This guide contains no doses.
The breathlessness
Around one in seven people taking ticagrelor develop dyspnoea - a sensation of breathlessness or air hunger, often at rest, frequently within the first week.
It is thought to result from ticagrelor's effect on adenosine signalling rather than on the heart or lungs, and it is usually mild, self-limiting and harmless, settling over days to weeks.
The problem is who it happens to. Someone recently discharged after a heart attack who becomes breathless reasonably fears the worst, and stopping the drug is exactly the wrong response after a stent.
Do not stop ticagrelor because of breathlessness without speaking to your cardiology team. They will want to exclude heart failure, anaemia and other causes - and if it is the drug, the options are to continue through it or switch to clopidogrel, not to stop antiplatelet treatment.
Being told to expect it in advance is what prevents most of the alarm.
Do not stop it after a stent
After a coronary stent, dual antiplatelet treatment continues for a defined period while the stent surface heals over.
Stopping early substantially raises the risk of the stent clotting off, which causes a heart attack and is frequently fatal.
That period is set by your cardiologist. Nobody should change it without speaking to them - including a dentist, a surgeon, or a GP treating something unrelated.
See clopidogrel.
Twice daily matters
Ticagrelor binds reversibly and has a short duration of action, so it is taken twice daily - unlike clopidogrel and prasugrel, which are once daily.
Reversible binding is an advantage before surgery, since platelet function recovers faster. It is a disadvantage day to day, because missing a dose leaves you less protected within hours.
Anchor both doses to fixed points rather than relying on memory - see remembering to take your medicine.
Only low-dose aspirin
This is a specific and important instruction. In the main ticagrelor trial, benefit was reduced in patients taking higher maintenance doses of aspirin.
Ticagrelor should therefore be taken with low-dose aspirin only.
That means not adding aspirin-containing cold remedies or higher-dose aspirin for pain. Read the ingredients panel rather than the brand name - see aspirin.
Bleeding
Ticagrelor is a more potent antiplatelet than clopidogrel, and bleeding is correspondingly more common.
Bruising, nosebleeds and bleeding gums are expected.
Seek urgent help for bleeding that will not stop, vomiting blood or material like coffee grounds, black tarry stools, blood in urine, a significant blow to the head, or sudden severe headache, weakness or confusion.
Anti-inflammatory painkillers add substantially to the risk - paracetamol is the usual alternative. See paracetamol.
Before surgery
Ticagrelor is usually stopped several days before surgery, and the interval is shorter than for clopidogrel because of the reversible binding.
Most dental treatment can be done without stopping it, using local measures. Do not stop it on your own initiative - ask the team who prescribed it, and get written instructions.
Bradycardia
Ticagrelor can cause pauses in heart rhythm, usually asymptomatic and mostly in the first week.
It is used with caution in people with sick sinus syndrome or heart block without a pacemaker.
Report fainting, marked dizziness or a very slow pulse - see medicines that affect your heart rhythm.
Interactions
Ticagrelor is cleared by CYP3A4, so strong inhibitors - clarithromycin, some antifungals, HIV boosters - raise levels and are avoided. Strong inducers such as carbamazepine and rifampicin reduce effectiveness.
See clarithromycin.
It raises simvastatin levels, so that dose is capped - see simvastatin. It also raises digoxin levels.
Grapefruit raises ticagrelor levels - see grapefruit and medicines.
Where it fits against clopidogrel
Clopidogrel needs converting to its active form by CYP2C19, and a substantial minority of people carry variants that make them poor converters - so clopidogrel works less well for them, and they do not know it.
Ticagrelor does not require that conversion, so its effect is consistent regardless of genetics. That is a real advantage after a heart attack, set against more bleeding and the twice-daily schedule. Which you are given is a cardiology decision weighing those.
Practical points
Tablets can be crushed and mixed with water for anyone who cannot swallow them, which is unusual among cardiac drugs and useful after a stroke or in hospital.
Do not run out - see ordering repeats.
Flecainide: Pill in the Pocket and Its Limits covers a related point, and the Conditions section has the rest of these guides.